What changed
🧭 Conviction: MED
Donaldson Company, Inc. manufactures and sells filtration systems and replacement parts worldwide.
🎯 FQ3 FY2026 (ends Apr) | reported Jun 02 | Rev $995M | Adj EPS $1.06 vs $1.05 🟢 | GAAP op margin 15.6%
💡 Consensus expected $1.05 adjusted EPS; DCI reported $1.06. The 1% beat is immaterial and does not signal an expectations gap. The market correctly anticipated stable results, leaving no variant view to exploit.
🏢 Business Quality: 7/10
📊 Valuation: fair
🔮 Catalyst: FQ3 FY2026 earnings reported on June 2,2026
⚖️ Avoid initiating a long position in DCI at current levels due to a flat reward/risk profile, no catalyst for re-rating, and a valuation that offers no margin of safety.
📊 Our read: AVOID. Full analysis →
https://stockduty.xyz/s/DCI0710
Also in play: $CAT $GE $GEV $RTX $DE